TenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting

Bulletin Express06-08

TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.

Key matters to be tabled as ordinary resolutions include: 1. 2025 work report of the Board of Directors 2. 2025 performance report of independent non-executive directors 3. 2025 annual financial report 4. 2025 profit distribution plan 5. Remuneration plan for the current Board session 6. Engagement of the Company’s auditor for the 2026 financial year

Voting at the ASM will be conducted by poll, with results to be published on the company’s website (www.tennortherapeutics.com) and HKEXnews (www.hkexnews.hk) following the meeting.

Shareholders may appoint proxies; completed proxy forms must reach Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, by 2:00 p.m. on Sunday, 28 June 2026. The H-share register will be closed from Wednesday, 24 June 2026, to Monday, 29 June 2026 (both dates inclusive). Shareholders listed on the register as of 29 June 2026 are entitled to attend and vote.

TenNor Therapeutics’ Board currently comprises one executive director (Dr. Ma Zhenkun), one non-executive director (Dr. Song Gaoguang), and three independent non-executive directors (Mr. Lee Wai Kong, Albert; Dr. Ni Lin; Dr. Li Leping). Dr. Ma serves as Chairman, Chief Executive Officer, and General Manager.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160842277?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160842277","market":"hk","top_or_hot":-1,"title":"TenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting","media":"Bulletin Express","content":"<p>TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.</p>\n<p>Key matters to be tabled as ordinary resolutions include:\n1. 2025 work report of the Board of Directors  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current Board session  \n6. Engagement of the Company’s auditor for the 2026 financial year</p>\n<p>Voting at the ASM will be conducted by poll, with results to be published on the company’s website (www.tennortherapeutics.com) and HKEXnews (www.hkexnews.hk) following the meeting.</p>\n<p>Shareholders may appoint proxies; completed proxy forms must reach Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, by 2:00 p.m. on Sunday, 28 June 2026. The H-share register will be closed from Wednesday, 24 June 2026, to Monday, 29 June 2026 (both dates inclusive). Shareholders listed on the register as of 29 June 2026 are entitled to attend and vote.</p>\n<p>TenNor Therapeutics’ Board currently comprises one executive director (Dr. Ma Zhenkun), one non-executive director (Dr. Song Gaoguang), and three independent non-executive directors (Mr. Lee Wai Kong, Albert; Dr. Ni Lin; Dr. Li Leping). Dr. Ma serves as Chairman, Chief Executive Officer, and General Manager.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-08 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.</p>\n<p>Key matters to be tabled as ordinary resolutions include:\n1. 2025 work report of the Board of Directors  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current Board session  \n6. Engagement of the Company’s auditor for the 2026 financial year</p>\n<p>Voting at the ASM will be conducted by poll, with results to be published on the company’s website (www.tennortherapeutics.com) and HKEXnews (www.hkexnews.hk) following the meeting.</p>\n<p>Shareholders may appoint proxies; completed proxy forms must reach Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, by 2:00 p.m. on Sunday, 28 June 2026. The H-share register will be closed from Wednesday, 24 June 2026, to Monday, 29 June 2026 (both dates inclusive). Shareholders listed on the register as of 29 June 2026 are entitled to attend and vote.</p>\n<p>TenNor Therapeutics’ Board currently comprises one executive director (Dr. Ma Zhenkun), one non-executive director (Dr. Song Gaoguang), and three independent non-executive directors (Mr. Lee Wai Kong, Albert; Dr. Ni Lin; Dr. Li Leping). Dr. Ma serves as Chairman, Chief Executive Officer, and General Manager.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06872","symbol_name":"丹诺医药-B","start_time":0,"source_url":"","article_id":"1160842277","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160842277","pubTimestamp":1780929800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06872":"丹诺医药-B"},"translate_title":"TenNor Therapeutics发布2025年年度股东大会通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06872":1},"content_text":"TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701, Block B7, BioBay, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu, PRC.\nKey matters to be tabled as ordinary resolutions include:\n1. 2025 work report of the Board of Directors  \n2. 2025 performance report of independent non-executive directors  \n3. 2025 annual financial report  \n4. 2025 profit distribution plan  \n5. Remuneration plan for the current Board session  \n6. Engagement of the Company’s auditor for the 2026 financial year\nVoting at the ASM will be conducted by poll, with results to be published on the company’s website (www.tennortherapeutics.com) and HKEXnews (www.hkexnews.hk) following the meeting.\nShareholders may appoint proxies; completed proxy forms must reach Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, by 2:00 p.m. on Sunday, 28 June 2026. The H-share register will be closed from Wednesday, 24 June 2026, to Monday, 29 June 2026 (both dates inclusive). Shareholders listed on the register as of 29 June 2026 are entitled to attend and vote.\nTenNor Therapeutics’ Board currently comprises one executive director (Dr. Ma Zhenkun), one non-executive director (Dr. Song Gaoguang), and three independent non-executive directors (Mr. Lee Wai Kong, Albert; Dr. Ni Lin; Dr. Li Leping). Dr. Ma serves as Chairman, Chief Executive Officer, and General Manager.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160842277","isCrawlerRequest":true}